Status:
COMPLETED
Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia
Lead Sponsor:
Ain Shams University
Conditions:
Epidural Anesthesia
Labor Pain
Eligibility:
FEMALE
21-40 years
Phase:
PHASE2
Brief Summary
The aim of this study is to compare epidural dexmedetomidine vs nalbuphine added to bupivacaine in labor analgesia and determine the privilege of one over the other and to compare the effect of both a...
Detailed Description
Labor pain often causes a strong stress response in women. Recently, it is concerned by most mothers and doctors that how to effectively alleviate the pain during delivery. There is no standard treatm...
Eligibility Criteria
Inclusion
- All the parturients should :
- Be between 21 - 40 years old
- ASA classification I- II
- Para 1-2
- Requesting analgesia
- Have a normal birth canal
- Be at the beginning of active phase of labor i.e. cervical dilatation of 4 cm with regular uterine contractions.
- The fetus should be a single full-term fetus (37- 42 weeks of gestation) with normal head position, normal development.
Exclusion
- Parturients
- Younger than 21 and older than 40 years old
- With contraindication of regional anesthesia
- With pre-existing neurological disease
- With history of allergy to the study drugs
- With cephalopelvic disproportion, fetal distress, amniotic fluid infection, placental insufficiency or scarred uterus
Key Trial Info
Start Date :
September 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05327088
Start Date
September 12 2021
End Date
March 12 2022
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt